What does it take to move from science into CEO leadership while delivering real impact for patients?
Recently, our CEO, Dr Adriana Kiedzierska-Mencfeld, was invited to join the Making It In Manufacturing podcast with Harry Sloan to share her perspective on leadership in biologics manufacturing.
Drawing on over 20 years of experience across biotech, biologics, and industry leadership, Adriana discusses how scientific expertise translates into real-world impact, and what it takes to lead in complex, high-pressure environments.
The discussion reflects the same principles that shape how we operate today as a biologics CDMO: quality, speed, cost-consciousness, and a strong client-centric mindset.
Key topics discussed:
- Transitioning from academia to the industry and the drive to turn science into real patient value
- Key leadership moments including entering new technology areas and managing high-pressure decision making
- Leading through COVID, maintaining operations and ensuring both product delivery and team safety
- Transforming into a biologics CDMO, dedicated to deliver value for our clients
- Competing in a crowded CDMO space through cost-efficiency, uncompromising quality and operational excellence
Watch the full episode:
We’d like to thank Harry Sloan and ARTO for giving us the opportunity to share our story and our vision for the future of biologics!
